Biobank and consortium find home

11.07.10 Stockholm – The Swedish Research Council is commissioning the Stockholm-based Karolinska Institute to host two new national infrastructures for research in biomedicine: the BioBanking and Molecular Resource Infrastructure of... more

Interview: New tools for personalised Dx

11.07.10 Personalised diagnostics open up possibilities for reducing adverse drug effects and choosing the most effective medicine for an individual patient based on a set of biomarkers. While many disease and stratification biomarkers... more

Funding for new RegMed-Centre

10.07.10 Stockholm – Sweden’s Karolinska Institute medical university has received a grant of EUR10m (SEK 100m) from the Knut and Alice Wallenberg Foundation for a regenerative medicine research centre. It will be named the Wallenberg... more

High blood levels of vitamin E reduces risk of Alzheimer’s

06.07.10 Stockholm – High levels of beta-tocopherol (vitamin E) in the blood appears to protect against the onset of Alzheimer's disease (AD) in advanced age, researchers at Sweden's Karolinska Institute have found out following a 6 year... more

Orexo seals EUR 600 million drug development deal

02.06.10 Uppsala - Swedish Orexo AB has licensed out its OX-CLI and OX-ESI programmes to Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica NV ("OMJ"). In addition to the programmes focusing on discovering and developing... more